Chemoinformaics analysis of Ethyl propyl disulfide
| Molecular Weight | 136.285 | nRot | 4 |
| Heavy Atom Molecular Weight | 124.189 | nRig | 11 |
| Exact Molecular Weight | 136.038 | nRing | 0 |
| Solubility: LogS | -2.696 | nHRing | 0 |
| Solubility: LogP | 3.226 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 22.1515 |
| nHD | 0 | BPOL | 14.4985 |
| QED | 0.684 |
| Synth | 2.557 |
| Natural Product Likeliness | 0.826 |
| NR-PPAR-gamma | 0.62 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.503 |
| MDCK | 0.0000238 |
| BBB | 0.216 |
| PPB | 0.950766 |
| VDSS | 1.857 |
| FU | 0.045292 |
| CYP1A2-inh | 0.768 |
| CYP1A2-sub | 0.907 |
| CYP2c19-inh | 0.885 |
| CYP2c19-sub | 0.602 |
| CYP2c9-inh | 0.711 |
| CYP2c9-sub | 0.924 |
| CYP2d6-inh | 0.036 |
| CYP2d6-sub | 0.237 |
| CYP3a4-inh | 0.198 |
| CYP3a4-sub | 0.214 |
| CL | 6.61 |
| T12 | 0.304 |
| hERG | 0.022 |
| Ames | 0.074 |
| ROA | 0.101 |
| SkinSen | 0.412 |
| Carcinogencity | 0.49 |
| EI | 0.975 |
| Respiratory | 0.12 |
| NR-Aromatase | 0.061 |
| Antiviral | No |
| Prediction | 0.950308 |